Abstract
The Trans-Atlantic Inter-Society Consensus (TASC) II class D femoral/popliteal lesions include chronic total occlusions (CTOs) of the superficial femoral artery (SFA) that are >20 cm in length or involve the popliteal artery. Primary stenting has proven superior to percutaneous transluminal balloon angioplasty (PTA) for FP CTOs [1]. Table 4.1 provides an overview of currently recommended treatment strategies of FP peripheral artery disease. Although surgical treatment may be preferred, current advancement of endovascular techniques and devices has made peripheral vascular intervention (PVI) often the first-line approach. Overall there are limited dedicated studies on stent versus non-stent approaches to FP CTOs. Treatment strategies for long occlusions of the SFA following successful recanalization have not been standardized, although these occlusions are frequently encountered in clinical practice. Stenting often leads to exaggerated neointimal hyperplasia leading to high in-stent restenosis rates (10–40% at 6–24 months) and stent fractures [2]. The subintimal approach can contribute to insufficient dilation and recoil after stent placement in the subintimal space, whereas the response to balloon dilation and self-expandable stenting can be more predictable and favorable with an intraluminal approach.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goetz JP, Kleemann M. Complex recanalization techniques for complex femoro-popliteal lesions: how to optimize outcomes. J Cardiovasc Surg. 2015;56:31–41.
Kasapis C, Henke PK, Chetcuti SJ, et al. Routine stent implantation vs percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta analysis of randomized controlled trials. Eur Heart J. 2009;30:44–55.
Hong SJ, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, Hong MK, Jang Y. Outcomes of spot stenting versus long stenting after intentional subintimal approach for long chronic total occlusions of the femoropopliteal artery. JACC Cardiovasc Interv. 2015;8(3):472–80.
Micari A, Vadalà G, Castriota F, Liso A, Grattoni C, Russo P, Marchese A, Pantaleo P, Roscitano G, Cesana BM, Cremonesi A. 1-year results of paclitaxel-coated balloons for long femoropopliteal artery disease: evidence from the SFA-long study. JACC Cardiovasc Interv. 2016;9(9):950–6.
Davaine JM, Querat J, Kaladji A, Guyomarch B, Chaillou P, Costargent A, Quillard T, Gouëffic Y. Treatment of TASC C and D Femoropoliteal Lesions with Paclitaxel eluting Stents: 12 month Results of the STELLA-PTX Registry. Eur J Vasc Endovasc Surg. 2015;50(5):631–7.
Matsumi J, Ochiai T, Tobita K, et al. Long-term outcomes of self-expandable nitinol stent implantation with intraluminal angioplasty to treat chronic total occlusion in the superficial femoral artery (TransAtlantic Inter-Society Consensus Type D lesions). J Invasive Cardiol. 2016;28:58–64.
Kruse RR, Poelmann FB, Doomernik D, Burgerhof HG, Fritschy WM, Moll FL, Reijnen MM. Five-year outcome of self-expanding covered stents for superficial femoral artery occlusive disease and an analysis of factors predicting failure. J Endovasc Ther 2015;22(6):855–61.
Zeller T, Rastan A, Macharzina R, et al. Drugcoated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther. 2014;21:359–68.
Norgren L et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Banerjee, S. (2017). Treatment of Femoropopliteal CTO. In: Banerjee, S. (eds) Practical Approach to Peripheral Arterial Chronic Total Occlusions. Springer, Singapore. https://doi.org/10.1007/978-981-10-3053-6_4
Download citation
DOI: https://doi.org/10.1007/978-981-10-3053-6_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-3052-9
Online ISBN: 978-981-10-3053-6
eBook Packages: MedicineMedicine (R0)